ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Injection of Adipose-Derived Mesenchymal Stem Cell-Enriched Adipose Extract for Temporomandibular Joint Osteoarthritis: A Randomised Controlled Trial.

顎関節症における脂肪由来間葉系幹細胞含有脂肪抽出物の関節内注射:ランダム化比較試験 (機械翻訳の邦題)

International dental journal2026Jing B, Zhang Z, Lv Y, et al.
研究デザインランダム化比較試験
対象ヒト

記録の確認項目

研究デザイン
ランダム化比較試験
対象
ヒト
出版年
2026
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/04
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

本研究は、顎関節症に対する脂肪由来間葉系幹細胞含有脂肪抽出物(ARDE)とヒアルロン酸(HA)の関節内注射の有効性を比較したランダム化比較試験である。保存的治療に反応しない、関節円板前方転位を伴わない患者50名(各群25名)を対象とし、関節洗浄後、対照群にはHA、研究群にはARDEを注射した。主要評価項目は疼痛VAS、副次評価項目は最大開口量(MMO)とMRI所見で、術前、1ヶ月後、6ヶ月後に評価した。6ヶ月後のVAS変化量はARDE群-4.9、HA群-4.3で有意差を認め(P=.009)、MMO変化量もARDE群1.7、HA群1.4で有意差を認めた(P=.022)。MRIではARDE群で関節液貯留の有意な改善を認めた(18/22 vs 6/20, P<.01)。ARDEはHAと比較し、疼痛緩和と機能改善に有望な可能性が示された。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Aims: This study aims to compare the efficacy of adipose-derived mesenchymal stem cells-enriched adipose extract (ARDE) with hyaluronic acid (HA) intra-articular injection in the treatment of temporomandibular joint osteoarthritis.Methods: The randomised controlled trial included patients who did not respond to conservative treatment, were diagnosed with anterior disc displacement without reduction according to the diagnostic criteria for Temporomandibular Disorders, and had a Visual Analogue Scale (VAS) score >4. After joint lavage, the control group received HA injections, while the study group received ARDE injections. The primary outcome included VAS scores for pain, while secondary outcome measures included maximum mouth opening (MMO) and magnetic resonance imaging results. Evaluations were performed at baseline, 1 month, and 6 months postoperatively.Results: A total of 50 patients were enrolled (25 per group), with comparable baseline characteristics between groups (P > .05). Analysis of covariance showed that the least-squares (LS) mean change in VAS score from baseline to month 6 in the ARDE vs HA groups was -4.9 vs -4.3 cm, respectively (LS mean difference, -0.7; 95% CI, -1.1 to -0.2; P = .009). For the MMO, the LS mean change was 1.7 vs 1.4 cm, respectively (LS mean difference, 0.3; 95% CI, 0 to 0.5; P = .022). Linear mixed-effects models verified significant group and time main effects for VAS score (both P < .001) and significant group main effect for MMO (P = .009), but no significant group-by-time interaction was found for either indicator (both P > .05). Magnetic resonance imaging indicated more significant resolution of preoperative joint effusion in ARDE group (18/22 vs 6/20, P < .01).Conclusion: ARDE injections demonstrate promising potential in relieving pain and improving joint function in patients with temporomandibular joint osteoarthritis, as compared with HA injections.

MeSH

Adipose TissueAdultFemaleHumansHyaluronic AcidInjections, Intra-ArticularMagnetic Resonance ImagingMaleMesenchymal Stem Cell TransplantationMesenchymal Stem CellsMiddle AgedOsteoarthritisPain MeasurementTemporomandibular Joint DisordersTreatment OutcomeViscosupplements

DOI 10.1016/j.identj.2026.109604

PMID 42134190

原文・出典を見る →